Porth's Essentials of Pathophysiology, 4e

204

Integrative Body Functions

U N I T 2

13. Makaryus AN, McFarlane SI. Diabetes insipidus: Diagnosis and treatment of a complex disease. Cleve Clin J Med. 2006;73(1):65–71. 14. Ditorgi N, Napoli F, Allegri AEM. Diabetes insidus—diagnosis and management. Horm Res Paediatr. 2012;77:69–84. 15. Sands JM, Bichet DG. Nephrogenic diabetes insipidus. Ann Intern Med. 2006;144:186–194. 16. Behan LA, Phillips J, Thompson LT, et al. Neuroendocrine disorders after traumatic brain injury. J Neurol Neurosurg Psychiatry. 2008;79:753–759. 17. Alexander MP, Farag YM, Mattal BV, et al. Lithium toxicity: a double-edged sword. Kidney Int. 2008;73(2):233–237. 18. Robertson GL. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med. 2006;119:S36–S42. 19. Hannon MJ, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: prevalence, causes, and consequences. Eur J Endocrinol. 2010;162:S5–S12. 20. Sherlock M, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: current and future management option. Eur J Endocrinol. 2010;162:S13–S18. 21. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;343:1581–1589. 22. Adrogue HJ, Madias NE. The challenge of hyponatremia. J Am Society Nephrol. 2012;23:1140–1148. 23. Vaidya C, Warren H, Freda BJ. Management of hyponatremia: Providing treatment and avoiding harm. Cleve Clin J Med. 2010;27(10):715–726. 24. Mount DB. The brain in hyonatremia: both culprit and victim. Semin Nephrol. 2009;29(3):196–215. 25. Murase T, Sugimura Y, Takefuji S, et al. Mechanisms and therapy of osmotic demyelination. Am J Med. 2006;119(7A):S69–S73. 26. Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med. 2000;342:1493–1499. 27. Sam R, Feizi I. Understanding hypernatremia. Am J Nephrol. 2012;36:97–104. 28. Al-Absi A, Gosmanova EO, Wall BM. The clinical approach to chronic hypernatremia. Am J Kidney Dis. 2012;60(6):1032–1038. 29. Rao MC. Oral rehydration therapy. Annl Rev Physiol. 2004;66:385–417. 30. Palmer BF, Dubose TD. Disorders of potassium metabolism. In: Scheir RW, ed. Renal and Electrolyte Disorders . 7th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2010:137–165. 31. Schaefer T, Wolford RW. Disorders of potassium. Emerg Med Clin North Am. 2005;23:723–747. 32. Palmer BF. A physiologic-based approach to the evaluation of a patient with hypokalemia. Am J Kidney Dis. 2010;56:1184–1190. 33. Pepin J, Shields C. Advances in diagnosis and management of hypokalemic and hyperkalemic emergencies. Emerg Med Pract. 2012;14(2):1–18. 34. Lehnhardt A, Kemper MJ. Pathogenesis, diagnosis and management of hyperkalemia. Pediatr Nephrol. 2011;26:377–384. 35. Moe SM. Disorders involving calcium, phosphorus, and magnesium. Prim Care. 2008;35(2):215–237. 36. Popovtzer MM. Disorders of calcium, phosphorus, vitamin D, and parathyroid hormone activity. In: Schrier RW, ed. Renal and Electrolyte Disorders . 7th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2010:166–228. 37. Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010;5:S23–S30. 38. Fong J, Khan A. Hypocalcemia. Can Fam Physician. 2012;58:158–162. 39. Liamis G, Millionis H, Elisaf M. A review of drug-induced hypocalcemia. J Bone Miner Metab. 2009;27:635–642.

40. Assadi F. Hypercalcemia: an evidence-based approach to clinical cases. Iran J Kidney Dis. 2009;3(2):71–79. 41. Stewart AF. Hypercalcemia associated with cancer. N Engl J Med. 2005;353(4):373–379. 42. Medaroov BL. Milk-alkali syndrome. Mayo Clin Proc. 2009;84(8): 261–267. 43. Ziegler R. Hypercalcemia crisis. J Am Soc Nephrol. 2001;12: S3–S9. 44. Leaf DE, Wolf M. A physiologic-based approach to evaluation of a patient with hyperphosphatemia. Am J Kidney Dis. 2013;61(2):330–336. 45. Felsenfeld AJ, Levine BS. Approach to treatment of hypophosphatemia. Am J Kidney Dis. 2012;60(4):655–661. 46. Hruska KA, Mathew S, Lund R, et al. Hyperphosphatemia of chronic kidney disease. Kidney Int. 2008;74(2):148–157. 47. Hsu HJ, Wu MS. Extreme hyperphosphaemia and hypocalcemic coma associated with phosphate enema. Intern Med. 2008;47(7):643–648. 48. Musso CG. Magnesium metabolism in health and disease. Int Urol Nephrol. 2009;41:357–362. 49. Guerrera ME, Volpe S, Mao JJ. Therapeutic uses of magnesium. Am Fam Physician. 2009;80(2):157–162. 50. Speigel DM. Normal and abnormal magnesium metabolism. In: Schrier RW, ed. Renal and Electrolyte Disorders . 7th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2010:229–250. 51. Gums JG. Magnesium in cardiovascular and other disorders. Am J Health Syst Pharm. 2004;61:1569–1576. 52. Fogleman CD. Magnesium sulfate and other anticonvulsants for women with preeclampsia. Am Fam Physician. 2011;83(11):1269–1271. 53. Topf JM, Murray PT. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord. 2003;4:195–206. 54. Martin KJ, Gonzalez EA, Slatopolsky E. Clincial consequences and management of hypomagnesemia. J Am Soc Nephrol. 2009;20:2291–2295. 55. Hoom EJ, van der Hoek J, de Mart RA, et al. A series of proton pump inhibitor-induced hypomagnesemia. Am J Kidney Dis. 2010;56(1):112–116. 56. Shoback D. Primary hypoparathyroidism. N Engl J Med. 2008;359(4):391–403. 57. Bilezikian JP, Khan A, Potts JT Jr, et al. Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target organ involvement, treatment, and challenges for the future. J Bone Mineral Res. 2011;26(10):2317–2337. 58. Mark SJ. Hypoparathyroid and hyperparathyroid disorders. N Engl J Med. 2000;343(25):1863–1875. 59. Taniegra ED. Hyperparathyroidism. Am Family Physician. 2004;69:333–339. 60. Ahmad R, Hammond JM. Primary, secondary, and tertiary hyperparathyroidism. Otolaryngol Clin North Am. 2004;17:703–713. 61. Marcocci C., Cetani F. Hyperparathyroidism. N Engl J Med. 2011;365(25):2389–2397. 62. Adrogue HE, Adrogue HJ. Acid–base physiology. Respir Care. 2001;46:328–341. 63. Koeppen BM. The kidney and acid–base balance. Adv Physiol Educ. 2009;33:275–281. 64. Whittier WL, Rutecki GW. Primer on clinical acid–base problem solving. Dis Mon. 2004;50:117–162. 65. Ralman S, Kaehny W, Shapiro JI. Pathogenesis of metabolic acidosis and alkalosis. In: Schrier RW, ed. Renal and Electrolyte Disorders . 7th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2010:86–121. 66. Kraut JA, Madas NE. Metabolic acidosis: Pathology, diagnosis, and management. Nat Rev Nephrol. 2010;6:274–285.